In line with patient data, we detected about two- to three-fold increase of the level of SULT1A1 mRNA and protein in TMX-resistant LCC2 breast cancer cells, derivative of MCF7 cells, obtained by Brunner et al. [21] (Fig. 1b). This evidence concerns the gene SULT1A1 and breast carcinoma.